Skip to main content
Top
Published in: Medical Gas Research 1/2011

Open Access 01-12-2011 | Commentary

Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?

Authors: Jun Mu, Paul R Krafft, John H Zhang

Published in: Medical Gas Research | Issue 1/2011

Login to get access

Abstract

Neurogenesis in adults, initiated by injury to the central nervous system (CNS) presents an autologous repair mechanism. It has been suggested that hyperbaric oxygen therapy (HBOT) enhances neurogenesis which accordingly may improve functional outcome after CNS injury. In this present article we aim to review experimental as well as clinical studies on the subject of HBOT and neurogenesis. We demonstrate hypothetical mechanism of HBOT on cellular transcription factors including hypoxia-inducible factors (HIFs) and cAMP response element binding (CREB). We furthermore reveal the discrepancy between experimental findings and clinical trials in regards of HBOT. Further translational preclinical studies followed by improved clinical trials are needed to elucidate potential benefits of HBOT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alvarez-Buylla A, Lim DA: For the long run: maintaining germinal niches in the adult brain. Neuron. 2004, 41 (5): 683-6. 10.1016/S0896-6273(04)00111-4.CrossRefPubMed Alvarez-Buylla A, Lim DA: For the long run: maintaining germinal niches in the adult brain. Neuron. 2004, 41 (5): 683-6. 10.1016/S0896-6273(04)00111-4.CrossRefPubMed
2.
go back to reference Mychaskiw G: Hyperbaric oxygen therapy and neurologic disease: the time has come. Undersea Hyperb Med. 2010, 37 (2): xi-xiii.PubMed Mychaskiw G: Hyperbaric oxygen therapy and neurologic disease: the time has come. Undersea Hyperb Med. 2010, 37 (2): xi-xiii.PubMed
3.
go back to reference Matchett GA, Martin RD, Zhang JH: Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms. Neurol Res. 2009, 31 (2): 114-21. 10.1179/174313209X389857.CrossRefPubMed Matchett GA, Martin RD, Zhang JH: Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms. Neurol Res. 2009, 31 (2): 114-21. 10.1179/174313209X389857.CrossRefPubMed
4.
go back to reference Wang XL, et al: Proliferation of neural stem cells correlates with Wnt-3 protein in hypoxic-ischemic neonate rats after hyperbaric oxygen therapy. Neuroreport. 2007, 18 (16): 1753-6. 10.1097/WNR.0b013e3282f0ec09.CrossRefPubMed Wang XL, et al: Proliferation of neural stem cells correlates with Wnt-3 protein in hypoxic-ischemic neonate rats after hyperbaric oxygen therapy. Neuroreport. 2007, 18 (16): 1753-6. 10.1097/WNR.0b013e3282f0ec09.CrossRefPubMed
5.
go back to reference Wang XL, et al: [Hyperbaric oxygen promotes the migration and differentiation of endogenous neural stem cells in neonatal rats with hypoxic-ischemic brain damage]. Zhongguo Dang Dai Er Ke Za Zhi. 2009, 11 (9): 749-52.PubMed Wang XL, et al: [Hyperbaric oxygen promotes the migration and differentiation of endogenous neural stem cells in neonatal rats with hypoxic-ischemic brain damage]. Zhongguo Dang Dai Er Ke Za Zhi. 2009, 11 (9): 749-52.PubMed
6.
go back to reference Zhang XY, et al: The role of beta-catenin signaling pathway on proliferation of rats neural stem cells after hyperbaric oxygen therapy in vitro. Cell Mol Neurobiol. 2011, 31 (1): 101-9. 10.1007/s10571-010-9559-z.CrossRefPubMed Zhang XY, et al: The role of beta-catenin signaling pathway on proliferation of rats neural stem cells after hyperbaric oxygen therapy in vitro. Cell Mol Neurobiol. 2011, 31 (1): 101-9. 10.1007/s10571-010-9559-z.CrossRefPubMed
7.
go back to reference Milosevic J, et al: Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells. Neurotox Res. 2009, 15 (4): 367-80. 10.1007/s12640-009-9043-z.CrossRefPubMed Milosevic J, et al: Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells. Neurotox Res. 2009, 15 (4): 367-80. 10.1007/s12640-009-9043-z.CrossRefPubMed
8.
go back to reference Tai PA, et al: Attenuating experimental spinal cord injury by hyperbaric oxygen: stimulating production of vasculoendothelial and glial cell line-derived neurotrophic growth factors and interleukin-10. J Neurotrauma. 2010, 27 (6): 1121-7. 10.1089/neu.2009.1162.CrossRefPubMed Tai PA, et al: Attenuating experimental spinal cord injury by hyperbaric oxygen: stimulating production of vasculoendothelial and glial cell line-derived neurotrophic growth factors and interleukin-10. J Neurotrauma. 2010, 27 (6): 1121-7. 10.1089/neu.2009.1162.CrossRefPubMed
10.
go back to reference Godman CA, et al: Hyperbaric oxygen treatment induces antioxidant gene expression. Ann N Y Acad Sci. 2010, 1197: 178-83. 10.1111/j.1749-6632.2009.05393.x.CrossRefPubMed Godman CA, et al: Hyperbaric oxygen treatment induces antioxidant gene expression. Ann N Y Acad Sci. 2010, 1197: 178-83. 10.1111/j.1749-6632.2009.05393.x.CrossRefPubMed
11.
go back to reference Yang YJ, et al: Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats. Undersea Hyperb Med. 2008, 35 (2): 113-29.PubMed Yang YJ, et al: Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats. Undersea Hyperb Med. 2008, 35 (2): 113-29.PubMed
12.
go back to reference Zhang T, et al: Hyperbaric oxygen therapy improves neurogenesis and brain blood supply in piriform cortex in rats with vascular dementia. Brain Inj. 2010, 24 (11): 1350-7. 10.3109/02699052.2010.504525.CrossRefPubMed Zhang T, et al: Hyperbaric oxygen therapy improves neurogenesis and brain blood supply in piriform cortex in rats with vascular dementia. Brain Inj. 2010, 24 (11): 1350-7. 10.3109/02699052.2010.504525.CrossRefPubMed
13.
go back to reference Gunther A, et al: Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci. 2005, 21 (11): 3189-94. 10.1111/j.1460-9568.2005.04151.x.CrossRefPubMed Gunther A, et al: Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci. 2005, 21 (11): 3189-94. 10.1111/j.1460-9568.2005.04151.x.CrossRefPubMed
14.
go back to reference Chen W, et al: HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis. 2008, 31 (3): 433-41. 10.1016/j.nbd.2008.05.020.PubMedCentralCrossRefPubMed Chen W, et al: HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis. 2008, 31 (3): 433-41. 10.1016/j.nbd.2008.05.020.PubMedCentralCrossRefPubMed
15.
go back to reference Lanfranconi S, et al: Growth factors in ischemic stroke. J Cell Mol Med. 2009, Lanfranconi S, et al: Growth factors in ischemic stroke. J Cell Mol Med. 2009,
16.
go back to reference Halterman MW, Federoff HJ: HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol. 1999, 159 (1): 65-72. 10.1006/exnr.1999.7160.CrossRefPubMed Halterman MW, Federoff HJ: HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol. 1999, 159 (1): 65-72. 10.1006/exnr.1999.7160.CrossRefPubMed
17.
go back to reference Mellor HR, Harris AL: The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev. 2007, 26 (3-4): 553-66. 10.1007/s10555-007-9080-0.CrossRefPubMed Mellor HR, Harris AL: The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev. 2007, 26 (3-4): 553-66. 10.1007/s10555-007-9080-0.CrossRefPubMed
19.
go back to reference Zhu DY, et al: Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA. 2004, 101 (25): 9453-7. 10.1073/pnas.0401063101.PubMedCentralCrossRefPubMed Zhu DY, et al: Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA. 2004, 101 (25): 9453-7. 10.1073/pnas.0401063101.PubMedCentralCrossRefPubMed
20.
go back to reference Mendoza-Paredes A, et al: Resuscitation with 100%, compared with 21%, oxygen following brief, repeated periods of apnea can protect vulnerable neonatal brain regions from apoptotic injury. Resuscitation. 2008, 76 (2): 261-70. 10.1016/j.resuscitation.2007.07.022.PubMedCentralCrossRefPubMed Mendoza-Paredes A, et al: Resuscitation with 100%, compared with 21%, oxygen following brief, repeated periods of apnea can protect vulnerable neonatal brain regions from apoptotic injury. Resuscitation. 2008, 76 (2): 261-70. 10.1016/j.resuscitation.2007.07.022.PubMedCentralCrossRefPubMed
21.
go back to reference Li JS, et al: Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Neuroscience. 2009, 159 (4): 1309-15. 10.1016/j.neuroscience.2009.01.011.CrossRefPubMed Li JS, et al: Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Neuroscience. 2009, 159 (4): 1309-15. 10.1016/j.neuroscience.2009.01.011.CrossRefPubMed
22.
go back to reference Taylor CT, et al: Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl Acad Sci USA. 2000, 97 (22): 12091-6. 10.1073/pnas.220211797.PubMedCentralCrossRefPubMed Taylor CT, et al: Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl Acad Sci USA. 2000, 97 (22): 12091-6. 10.1073/pnas.220211797.PubMedCentralCrossRefPubMed
23.
go back to reference Lichtenwalner RJ, Parent JM: Adult neurogenesis and the ischemic forebrain. J Cereb Blood Flow Metab. 2006, 26 (1): 1-20. 10.1038/sj.jcbfm.9600170.CrossRefPubMed Lichtenwalner RJ, Parent JM: Adult neurogenesis and the ischemic forebrain. J Cereb Blood Flow Metab. 2006, 26 (1): 1-20. 10.1038/sj.jcbfm.9600170.CrossRefPubMed
24.
go back to reference Shin HY, et al: Endogenous neurogenesis and neovascularization in the neocortex of the rat after focal cerebral ischemia. J Neurosci Res. 2008, 86 (2): 356-67. 10.1002/jnr.21494.CrossRefPubMed Shin HY, et al: Endogenous neurogenesis and neovascularization in the neocortex of the rat after focal cerebral ischemia. J Neurosci Res. 2008, 86 (2): 356-67. 10.1002/jnr.21494.CrossRefPubMed
25.
go back to reference Singhal AB: A review of oxygen therapy in ischemic stroke. Neurol Res. 2007, 29 (2): 173-83. 10.1179/016164107X181815.CrossRefPubMed Singhal AB: A review of oxygen therapy in ischemic stroke. Neurol Res. 2007, 29 (2): 173-83. 10.1179/016164107X181815.CrossRefPubMed
26.
go back to reference Poli S, Veltkamp R: Oxygen therapy in acute ischemic stroke-experimental efficacy and molecular mechanisms. Curr Mol Med. 2009, 9 (2): 227-41. 10.2174/156652409787581619.CrossRefPubMed Poli S, Veltkamp R: Oxygen therapy in acute ischemic stroke-experimental efficacy and molecular mechanisms. Curr Mol Med. 2009, 9 (2): 227-41. 10.2174/156652409787581619.CrossRefPubMed
27.
go back to reference Yin D, et al: Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab. 2003, 23 (7): 855-64.CrossRefPubMed Yin D, et al: Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab. 2003, 23 (7): 855-64.CrossRefPubMed
28.
go back to reference Yin D, Zhang JH: Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model. Neurocrit Care. 2005, 2 (2): 206-11. 10.1385/NCC:2:2:206.CrossRefPubMed Yin D, Zhang JH: Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model. Neurocrit Care. 2005, 2 (2): 206-11. 10.1385/NCC:2:2:206.CrossRefPubMed
29.
go back to reference Sun L, et al: Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab. 2010, 30 (9): 1651-60. 10.1038/jcbfm.2010.50.PubMedCentralCrossRefPubMed Sun L, et al: Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab. 2010, 30 (9): 1651-60. 10.1038/jcbfm.2010.50.PubMedCentralCrossRefPubMed
30.
go back to reference Carson S, et al: Hyperbaric oxygen therapy for stroke: a systematic review of the evidence. Clin Rehabil. 2005, 19 (8): 819-33. 10.1191/0269215505cr907oa.CrossRefPubMed Carson S, et al: Hyperbaric oxygen therapy for stroke: a systematic review of the evidence. Clin Rehabil. 2005, 19 (8): 819-33. 10.1191/0269215505cr907oa.CrossRefPubMed
31.
go back to reference Bennett MH, et al: Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2005, CD004954-3 Bennett MH, et al: Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2005, CD004954-3
32.
go back to reference Kernie SG, Parent JM: Forebrain neurogenesis after focal Ischemic and traumatic brain injury. Neurobiol Dis. 2010, 37 (2): 267-74. 10.1016/j.nbd.2009.11.002.PubMedCentralCrossRefPubMed Kernie SG, Parent JM: Forebrain neurogenesis after focal Ischemic and traumatic brain injury. Neurobiol Dis. 2010, 37 (2): 267-74. 10.1016/j.nbd.2009.11.002.PubMedCentralCrossRefPubMed
33.
go back to reference McDonagh M, et al: Hyperbaric oxygen therapy for traumatic brain injury: a systematic review of the evidence. Arch Phys Med Rehabil. 2004, 85 (7): 1198-204. 10.1016/j.apmr.2003.12.026.CrossRefPubMed McDonagh M, et al: Hyperbaric oxygen therapy for traumatic brain injury: a systematic review of the evidence. Arch Phys Med Rehabil. 2004, 85 (7): 1198-204. 10.1016/j.apmr.2003.12.026.CrossRefPubMed
34.
go back to reference Rockswold SB, Rockswold GL, Defillo A: Hyperbaric oxygen in traumatic brain injury. Neurol Res. 2007, 29 (2): 162-72. 10.1179/016164107X181798.CrossRefPubMed Rockswold SB, Rockswold GL, Defillo A: Hyperbaric oxygen in traumatic brain injury. Neurol Res. 2007, 29 (2): 162-72. 10.1179/016164107X181798.CrossRefPubMed
35.
go back to reference Meyer MJ, et al: Acute management of acquired brain injury part I: an evidence-based review of non-pharmacological interventions. Brain Inj. 2010, 24 (5): 694-705. 10.3109/02699051003692118.CrossRefPubMed Meyer MJ, et al: Acute management of acquired brain injury part I: an evidence-based review of non-pharmacological interventions. Brain Inj. 2010, 24 (5): 694-705. 10.3109/02699051003692118.CrossRefPubMed
36.
go back to reference Wegiel J, et al: The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010, 119 (6): 755-70. 10.1007/s00401-010-0655-4.PubMedCentralCrossRefPubMed Wegiel J, et al: The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010, 119 (6): 755-70. 10.1007/s00401-010-0655-4.PubMedCentralCrossRefPubMed
37.
go back to reference Rossignol DA, et al: Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009, 9: 21-10.1186/1471-2431-9-21.PubMedCentralCrossRefPubMed Rossignol DA, et al: Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009, 9: 21-10.1186/1471-2431-9-21.PubMedCentralCrossRefPubMed
38.
go back to reference Jepson B, et al: Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders. J Autism Dev Disord. 2011, 41 (5): 575-88. 10.1007/s10803-010-1075-y.CrossRefPubMed Jepson B, et al: Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders. J Autism Dev Disord. 2011, 41 (5): 575-88. 10.1007/s10803-010-1075-y.CrossRefPubMed
39.
go back to reference Palmer TD, Willhoite AR, Gage FH: Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. 2000, 425 (4): 479-94. 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3.CrossRefPubMed Palmer TD, Willhoite AR, Gage FH: Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. 2000, 425 (4): 479-94. 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3.CrossRefPubMed
40.
go back to reference Feldmeier J, et al: Hyperbaric oxygen: does it promote growth or recurrence of malignancy?. Undersea Hyperb Med. 2003, 30 (1): 1-18.PubMed Feldmeier J, et al: Hyperbaric oxygen: does it promote growth or recurrence of malignancy?. Undersea Hyperb Med. 2003, 30 (1): 1-18.PubMed
41.
go back to reference Taupin P: A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. Cent Nerv Syst Agents Med Chem. 2010, 10 (1): 16-21.CrossRefPubMed Taupin P: A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. Cent Nerv Syst Agents Med Chem. 2010, 10 (1): 16-21.CrossRefPubMed
Metadata
Title
Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?
Authors
Jun Mu
Paul R Krafft
John H Zhang
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Medical Gas Research / Issue 1/2011
Electronic ISSN: 2045-9912
DOI
https://doi.org/10.1186/2045-9912-1-14

Other articles of this Issue 1/2011

Medical Gas Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine